A detailed history of Sit Investment Associates Inc transactions in Vericel Corp stock. As of the latest transaction made, Sit Investment Associates Inc holds 64,495 shares of VCEL stock, worth $3.69 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
64,495
Previous 59,745 7.95%
Holding current value
$3.69 Million
Previous $2.74 Million 0.58%
% of portfolio
0.06%
Previous 0.06%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$42.25 - $53.56 $200,687 - $254,410
4,750 Added 7.95%
64,495 $2.73 Million
Q2 2024

Aug 14, 2024

BUY
$41.71 - $52.9 $757,745 - $961,034
18,167 Added 43.69%
59,745 $2.74 Million
Q1 2024

May 14, 2024

BUY
$32.52 - $52.33 $423,670 - $681,755
13,028 Added 45.63%
41,578 $2.16 Million
Q4 2023

Feb 13, 2024

BUY
$30.85 - $37.09 $158,106 - $190,086
5,125 Added 21.88%
28,550 $1.02 Million
Q3 2023

Nov 13, 2023

BUY
$31.69 - $39.25 $742,338 - $919,431
23,425 New
23,425 $785,000

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.7B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Sit Investment Associates Inc Portfolio

Follow Sit Investment Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sit Investment Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Sit Investment Associates Inc with notifications on news.